The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Targeting leukocyte MMPs and transmigration
Open accessAbstract
Multiple sclerosis is characterized by the infiltration of leukocytes into the CNS. As matrix metalloproteinases (MMPs) facilitate the passage of leukocytes across matrix barriers, we tested the hypothesis that targeting MMPs could attenuate neuro-inflammation. We report that minocycline, a widely used generic drug with a good safety record, inhibited MMP activity, reduced production of MMP-9 and decreased the transmigration of T lymphocytes across a fibronectin matrix barrier. In addition, minocycline was efficacious against both mild and severe experimental autoimmune encephalomyelitis (EAE) in mice, an animal model of multiple sclerosis. When severe EAE was produced, minocycline pre-treatment delayed the course of the disease: when maximal disease activity occurred in vehicle-treated EAE mice, minocycline animals were relatively normal and had minimal signs of inflammation and demyelination in the CNS. When tested in mice afflicted with mild EAE, minocycline attenuated the clinical severity of disease throughout the course of treatment. These results indicate that minocycline may constitute a safe and inexpensive therapy for multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Metalloproteinases in biology and pathology of the nervous system
Yong, V. W., Power, C., Forsyth, P., & Edwards, D. R. (2001) · Nature Reviews Neuroscience · doi:10.1038/35081571 · Cited by 1,060
Self-citationChen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K. B., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,051
Yrjänheikki, J., Tikka, T., Keinänen, R., Goldsteins, G., Chan, P. H., & Koistinaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,038
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Self-citationChen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547
Tikka, T. M., & Koistinaho, J. E. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 530
Hohlfeld, R. (1997) · Brain · doi:10.1093/brain/120.5.865 · Cited by 365
Clinical Pharmacokinetics of Doxycycline and Minocycline
Saivin, S., & Houin, G. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815060-00001 · Cited by 350
Stüve, O., Dooley, N. P., Uhm, J. H., Antel, J. P., Francis, G. S., Yong, V. W., & Williams, G. (1996) · Annals of Neurology · doi:10.1002/ana.410400607 · Cited by 348
Self-citationGolub, L. M., Ramamurthy, N., McNamara, T. F., Gomes, B., Wolff, M., Casino, A., Kapoor, A., Zambon, J., Ciancio, S., Schneir, M., et al. (1984) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1984.tb01334.x · Cited by 313
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome: Table 2
Gough, A., Chapman, S., Wagstaff, K., Emery, P., & Elias, E. (1996) · BMJ · doi:10.1136/bmj.312.7024.169 · Cited by 311
Leppert, D., Waubant, E., Bürk, M. R., Oksenberg, J. R., & Hauser, S. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400606 · Cited by 291
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
Bernard, C. C. A., Johns, T. G., Slavin, A., Ichikawa, M., Ewing, C., Liu, J., & Bettadapura, J. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050092 · Cited by 270
Self-citationMatrix Metalloproteinase-9/Gelatinase B Is Required for Process Outgrowth by Oligodendrocytes
Oh, L. Y. S., Larsen, P. H., Krekoski, C. A., Edwards, D. R., Donovan, F., Werb, Z., & Yong, V. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08464.1999 · Cited by 267
Self-citationDubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den Oord, J., Sciot, R., Meinhardt, T., Hämmerling, G., Opdenakker, G., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6886 · Cited by 262
Caton, J. G., Ciancio, S. G., Blieden, T. M., Bradshaw, M., Crout, R. J., Hefti, A. F., Massaro, J. M., Polson, A. M., Thomas, J., & Walker, C. (2000) · Journal of Periodontology · doi:10.1902/jop.2000.71.4.521 · Cited by 252
Leppert, D. (1998) · Brain · doi:10.1093/brain/121.12.2327 · Cited by 251
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
Waubant, E., Goodkin, D. E., Gee, L., Bacchetti, P., Sloan, R., Stewart, T., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234
Comparative Safety of Tetracycline, Minocycline, and Doxycycline
Shapiro, L. E. (1997) · Archives of Dermatology · doi:10.1001/archderm.133.10.1224 · Cited by 231
Cytokine-regulated proteases in autoimmune diseases
Opdenakker, G., & Damme, J. V. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90151-1 · Cited by 210
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis
Lee, M. A., Palace, J., Stabler, G., Ford, J., Gearing, A., & Miller, K. (1999) · Brain · doi:10.1093/brain/122.2.191 · Cited by 199
Vecil, G. G., Larsen, P. H., Corley, S. M., Herx, L. M., Besson, A., Goodyer, C. G., & Yong, V. W. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000715)61:2<212::aid-jnr12>3.0.co;2-9 · Cited by 191
Self-citationAnthony, D. C., Miller, K. M., Fearn, S., Townsend, M. J., Opdenakker, G., Wells, G. M. A., Clements, J. M., Chandler, S., Gearing, A. J. H., & Perry, V. H. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00046-0 · Cited by 180
Minocycline-induced autoimmune syndromes: An overview
Elkayam, O., Yaron, M., & Caspi, D. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80004-3 · Cited by 172
Matrix metalloproteinases in inflammatory demyelination: Targets for treatment
Kieseier, B. C., Seifert, T., Giovannoni, G., & Hartung, H.-P. (1999) · Neurology · doi:10.1212/wnl.53.1.20 · Cited by 167
Newman, T. A., Woolley, S. T., Hughes, P. M., Sibson, N. R., Anthony, D. C., & Perry, V. H. (2001) · Brain · doi:10.1093/brain/124.11.2203 · Cited by 144
Galboiz, Y., Shapiro, S., Lahat, N., Rawashdeh, H., & Miller, A. (2001) · Annals of Neurology · doi:10.1002/ana.1218 · Cited by 125
Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
Trojano, M., Avolio, C., Liuzzi, G. M., Ruggieri, M., Defazio, G., Liguori, M., Santacroce, M. P., Paolicelli, D., Giuliani, F., Riccio, P., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1402 · Cited by 125
Minocycline and Lupuslike Syndrome in Acne Patients
Sturkenboom, M., Meier, C. R., Jick, H., & Stricker, B. H. C. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.493 · Cited by 116
Paemen, L. R., Martens, E., Norga, K., Masure, S., Roets, E., Hoogmartens, J., & Opdenakker, G. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00168-2 · Cited by 107
Lichtinghagen, R., Seifert‐Held, T., Kracke, A., Marckmann, S., Wurster, U., & Heidenreich, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00094-6 · Cited by 95
Kardong, K. V., & Berkhoudt, H. (1998) · Brain Behavior and Evolution · doi:10.1159/000006579 · Cited by 65
Minocycline-induced Lupus in Adolescents
Akin, E. U., Miller, L. C., & Tucker, L. B. (1998) · PEDIATRICS · doi:10.1542/peds.101.5.926 · Cited by 50
Thomas, J. G., Metheny, R. J., Karakiozis, J. M., Wetzel, J., & Crout, R. J. (1998) · Advances in Dental Research · doi:10.1177/08959374980120011601 · Cited by 49
Benefit-risk assessment of acne therapies
Seukeran, D. C., Eady, E. A., & Cunliffe, W. J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62445-2 · Cited by 37
The potential use of MMP inhibitors to treat CNS diseases
Yong, V. W. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.3.255 · Cited by 36
Self-citationIngham, E. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/26.1.61 · Cited by 26
Matrix metalloproteinases in multiple sclerosis: Is it time for a treatment trial?
Rosenberg, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.1236 · Cited by 20
Cited by
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Constantinescu, C. S., Farooqi, N., O'Brien, K., & Gran, B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01302.x · Cited by 1,523
Minocycline: Far beyond an Antibiotic
Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Tetracyclines: Nonantibiotic properties and their clinical implications
Sapadin, A. N., & Fleischmajer, R. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.10.004 · Cited by 768
Metadata
- Authors
- Brundula, V., Rewcastle, N. B., Metz, L. M., Bernard, C. C., & Yong, V. W.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06
- Volume
- 125
- Issue
- 6
- Pages
- 1297-1308
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2286903127
- Cited by
- 426
- References
- 42
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.